The effect of altitude-induced hypoxia on heart disease: Do acute, intermittent, and chronic exposures provide cardioprotection?

High Altitude Medicine and Biology

Volumn 12, Issue 1, 2011, Pages 45-55

  Anderson, John D ^a   Honigman, Benjamin ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

altitude; cardioprotection; coronary artery disease; hypoxia; hypoxia inducible factor

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; ENDOTHELIN 1; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; ION CHANNEL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE 4; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ALTITUDE; APOPTOSIS; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; GENDER; GENE EXPRESSION; GENETICS; HEART DISEASE; HEART FUNCTION; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOXIA; IMMOBILIZATION; METABOLISM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; VASCULARIZATION;

ALTITUDE; ANOXIA; HEART DISEASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; REACTIVE OXYGEN SPECIES; RISK FACTORS; TIME;

EID: 79953816440     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2010.1021     Document Type: Review

References (112)

1. Alexander J.K. (1994). Coronary heart disease at altitude. Texas Heart Inst. J. 21(4):261-266.
2. Al-Huthi M.A., Raja'a Y.A., Al-Noami M., and Abdul Rahman A.R. (2006). Prevalence of coronary risk factors, clinical presentation, and complications in acute coronary syndrome patients living at high vs. low altitudes in Yemen. Med. Gen. Med. 8:28.
3. Al Tahan A., Buchur J., el Khwsky F., Ogunniyi A., al-Rajeh S., Larbi E., Daif A., and Bamgboye E. (1998). Risk factors of stroke at high and low altitude areas in Saudi Arabia. Arch. Med. Res. 29:173-177.
4. Arias-Stella J., and Topilsky M. (1971). Anatomy of the coronary circulation at high altitude. In: High Altitude Physiology: Cardiac and Respiratory Aspects. R. Porter and J. Knight, eds. Churchill Livingstone, Edinburgh; pp. 149-154.
5. Asemu E.F., Neckar J., Szarszi O., and Papousek F. (2000). Effects of adaptation to intermittent high altitude hypoxia on ischemic ventricular arrhythmias in rats. Physiol. Res. 49:597-606.
6. Asemu G., Papousek F., Ostadal B., and Kolar F. (1999). Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias: involvement of mitochondrial K(ATP) channel. J. Mol. Cell Cardiol. 31(10):1821-1831.
7. Baibas N., Trichopoulou A., Voridis E., and Trichopoulos D. (2005). Residence in mountainous compared with lowland area in relation to total and coronary mortality; a study in rural Greece. J. Epidemiol. Community Health. 59:274-278.
8. Basu A., Gupta R., Mitra P., and Dewanji A. (1984). Variation in resting BP in relation to age, body build and altitude among the Sherpas of the eastern Himalaya. In: Proceedings of the Indian Statistical Institute Golden Jubilee International Conference of Human Genetics and Adaptation, Vol. 2, Human Adaptation. A. Basu and K. C. Malhotra, eds. Indian Statistical Institute, Calcutta; pp. 60-69.
9. Baker J.E., Holman P., Kalyanaraman B., et al. (1999). Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric ozide production. Ann. N.Y. Acad. Sci. 874:236-253.
10. Bärtch P., and Gibbs S. (2007). Effect of altitude on the heart and lungs. Circulation. 116:2191-2202.
11. Bärtch P., and Saltin B. (2008). General introduction to altitude adaptation and mountain sickness. Scand. J. Med. Sci. Sports. 18:1-10.
12. Boehm E.A., Jones B.E., Radda G.K., et al. (2001). Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am. J. Physiol. Heart. Circ. Physiol. 280:H977-H983.
13. Budas G.R., Churchill E.N., and Mochly-Rosen D. (2007). Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol. Res. 55(6):523-536.
14. Buechley R., Key C., and Morris D. (1979). Altitude and ischemic heart disease in tri-cultural New Mexico: an example of confounding. Am. J. Epidemiol. 109:663-666.
15. Cai Z., Manalo D., Wei G., et al. (2003). Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia reperfusion injury. Circulation. 108:79-85. (Pubitemid 36859024)
16. Chen L., Einbinder E., Zhang Q., et al. (2005). Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am. J. Resp. Crit. Care Med. 172:915-920.
17. Chen L., Lu X.Y., and Li J. (2006). Intermittent hypoxia protects cardiomyocytes against ischemia reperfusion injury-induced alterations in Ca2+ homeostasis and contraction via the sarcoplasmic reticulum and Na+/Ca2+ exchange mechanisms. Am. J. Physiol. Cell Physiol. 290:1221-1229.
18. Coello S.D., De Leon A.C., Ojeda F.B., et al. (2000). High density lipoprotein cholesterol increases with living at altitude. Int. J. Epidemiol. 29:65-70.
19. Cohen J.E., and Small C. (1998). Hypographic demography: the distribution of human population by altitude. Proc. Natl. Acad. Sci. USA. 95:14009-14014.
20. Daneshrad Z., Garcia-Riera M., Verdys M., et al. (2000). Differential responses to chronic hypoxia and dietary restriction of aerobic capacity and enzyme levels in the rat myocardium. Mol. Cell Biochem. 210:159-166.
21. D'Agostino R.B., Vasan R.S., Pecina M.J., Wolf P.A., Cobain M., Massaro J.M., and Kannel W.B. (2008). General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117(6):743-753. (Pubitemid 351640675)
22. Dasgupta D., Prasher B., Vaidya N., et al. (1982). Blood pressure in a community at high altitude (3000 m) at Pooh (North India). J. Epidemiol. Community Health. 36:251-255. (Pubitemid 13247458)
23. Deindle E., Kolar F., Neubauer E., et al. (2003). Effect of intermittent hypoxia on gene expression in the rat heart and lung. Physiol. Res. 52:147-157.
24. Ding H., Zhu H., Dong J., et al. (2004). Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C. Life Sci. 75:2587-2603. (Pubitemid 39195264)
25. Ding H., Zhu H., Dong J., et al. (2005). Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/ reperfusion injury. Acta Pharm. Sinica. 26:315-322.
26. Dorn G.W., Souroujon M.C., and Liron T., et al. (1999). Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc. Natl. Acad. Sci. USA. 96(22):12798-12803.
27. Essop M.F. (2007). Cardiac metabolic adaptations in response to chronic hypoxia. J. Physiol. 584:715-726.
28. Fabsitz R., and Feinleib M. (1980). Geographic patterns in county mortality rates from cardiovascular diseases. Am. J. Epidemiol. 111:315-328.
29. Faeh D., Gutzwiller F., and Bopp M. (2009). Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 120(6):495-501.
30. Ferdinandy P., and Schulz R. (2003). Nitric oxide, superoxide and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138:532-543.
31. Ferezou J., Richalet J., Serougne C., et al. (1993). Reduction of postprandial lipemia after acute exposure to high altitude hypoxia. Int. J. Sports Med. 14:78-85.
32. Ferreiro C., Chagas A.C., Carvalho M.H., et al. (2001). Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: a novel pathophysiological adaptive mechanism. Circulation. 203:2272-2276. (Pubitemid 32433717)
33. Fitzpatrick C.M., Shi Y., Hutchins W.C., et al. (2005). Cardioprotection in chronically hypoxic rabbits persists upon exposure to normoxia: role of nitric oxide synthase and Katp channels. Am. J. Physiol. Heart Circ. Physiol. 288:H62-H68.
34. Forkel J., Chen X., Wandinger S., et al. (2004). Responses of chronically hypoxic rat hearts to ischemia: Katp channel blockade does not abolish increased RV tolerance to ischemia. Am. J. Physiol. 286:H545-H551.
35. Fujimoto N., Matsubayashi K., Miyahara T., et al. (1989). The risk factors for ischemic heart disease in Tibetan highlanders. Jpn. Heart J. 30:27-34.
36. Fung M.L. (2003). Hypoxia-inducible factor-1: a molecular hint of physiological changes in the carotid body during long term hypoxemia? Curr. Drug Targets Cardiovasc. Haematol. Disord. 3:254-259.
37. Gao W., Ferguson G., Connell P., et al. (2007). High glucose concentrations alter hypoxia induced control of vascular smooth muscle growth via a HIF-1α dependent pathway. J. Mol. Cell Cardiol. 42:609-619.
38. Gore C., Rodriguez F.A., Truijens M.J., et al. (2006). Increased serum erythropoietin but not red cell production after 4 weeks of intermittent hypobaric hypoxia. J. Appl. Physiol. 101:1386-1393.
39. Graham R.M., Frazier D.P., Thompson J.W., et al. (2004). A unique pathway of cardiac myocyte death caused by hypoxia acidosis. J. Exp. Biol. 207:3189-3200.
40. Granfeldt A., Lefer D.J., and Vinten-Johansen J. (2009). Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc. Res. 83(2):234-246.
41. Gray M.O., Zhou H.Z., Schafhalter-Zoppoth I., et al. (2004). Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J. Biol. Chem. 279(5):3596-3604.
42. Grilli A., DeLutiis A., Patruno A, et al. (2003). Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Am. Clin. Lab.Sci. 33:208-215.
43. Hainesworth R., Drinkhill M.J., and Rivera-Chira M. (2007). The autonomic nervous system at high altitude. Clin. Auton. Res. 17:13-19.
44. Hanna J. (1999). Climate, altitude and blood pressure. Hum. Biol. 71(4):553-582.
45. Hochachka P. (1998). Mechanism and evolution of hypoxia-tolerance in humans. J. Exp. Biol. 201:1243-1254.
46. Husenloy D.J., and D.M. Yellon. (2008). Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 204:334-341.
47. Hu J., Discher D.J., Bishopric N.H., and Webster K.A. (1998). Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245(3): 894-899.
48. Hurtado A. (1960). Some clinical aspects of life at high altitudes. Ann. Intern. Med. 53:247-258.
49. Inagaki K., Hahn H.S., Dorn G.W., and Mochley-Rosen D. (2003). Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation. 108(7):869-875. (Pubitemid 37022131)
50. Kolar F., Jezkova J., Balkova P., et al. (2007). Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia. Am. J. Physiol. Heart Circ. Physiol. 292(1):H224-H230.
51. Kolar F., and Ostadal B. (2004). Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol. Res. 53(1):S3-S13.
52. Levine B., Zuckerman J., and deFilippi C.(1997). Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study. Circulation. 96:1224-1232.
53. Lundberg J.O., and Weitzberg E. (2005). NO generation from nitrite and its role in vascular control. Arterioscl. Thromb. Vasc. Biol. 25:915-922.
54. Marshall J.M. (1994). Peripheral chemoreceptors and cardiovascular regulation. Physiol. Rev. 74:543-594.
55. Marshall J.M., annd Metcalf J.D. (1988). Analysis of cardiovascular changes induced in the rat by graded levels of systemic hypoxia. J. Physiol. 407:385-403.
56. Marshall J.M., and Metcalf J.D. (1989). Analysis of factors that contribute to cardiovascular changes induced in the cat by graded levels of systemic hypoxia. J. Physiol. 412:429-448. (Pubitemid 19134492)
57. Marticorena E., Ruiz L., Saverino J., et al. (1969). Systemic blood pressure in white men born at sea level: changes after long residence at high altitude. Am. J. Cardiol. 23:364-368.
58. Mazzeo R.S., Bender P.R., Brooks G.A., et al. (1991). Arterial catecholamine response during exercise with acute and chronic high altitude exposure. Am. J. Physiol. 261:E419-E424.
59. Mazzeo R.S., Child A., Butterfield G.E., et al. (1998). Catecholamine response during 12 days of high altitude exposure in women. J. Appl. Physiol. 84:1151-1157.
60. McGrath J.J., Prochazka J., Pelouch V., and Ostadal B. (1973). Physiological response of rats to intermittent high altitude stress: effect of age. J. Appl. Physiol. 34:289-293.
61. Meerson F.Z., Ustinova E.E., and Orlova E.H. (1989). Prevention of cardiac arrhythmias by adaptation: regulatory mechanisms and cardiotrophic effect. Biomed. Biochem. Acta. 48:583-588.
62. Mendoza S., Nuchete H., Ineichen E., et al. (1979). Lipids and lipoproteins in subjects at 1000 and 3500 meter altitude. Arch. Environ. Health. 34:308-311.
63. Messerli-Burgi N., Meyer K., Steptoe A., and Laederach-Hofmann K. (2009). Autonomic and cardiovascular effects of acute high altitude exposure after myocardial infarction and in normal volunteers. Circ. J. 73(8):1485-1491.
64. Milano G., Corno A.F., Lippa S., Von Segesser L.K., and Samaja M. (2002). Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia induced dysfunction. Exp. Biol. Med. 227(6):389-397.
65. Moret P.R., Covarrubias E., Coudert J., and Duchosal F. (1972a). Cardiocirculatory adaptation to chronic hypoxia.I: comparative study of coronary flow, myocardial oxygen consumption and efficiency between sea level and high altitude residents. Acta Cardiol. 27:283-291.
66. Moret P.R., Covarrubias E., Coudert J., and Duchosal F. (1972b). Cardiocirculatory adaptation to chronic hypoxia.II: comparative study of myocardial metabolism of glucose, lactate, pyruvate and free fatty acids between sea level and high altitude residents. Acta Cardiol. 27(4):483-503.
67. Mortimer E.A. Jr., Monson R.R., and Macmahon B. (1977). Reduction in mortality from coronary heart disease in men residing at high altitude. N. Engl. J. Med. 296:581-585.
68. Murphy E., and Steenbergen C. (2008). Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88:581-609.
69. Murray C.E., Jennings R.B., and Reimer K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1124-1136. (Pubitemid 17174962)
70. Murray C.J., Kulkarni S.C., and Ezzati M. (2006). Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation. 113(17):2071-2081.
71. Murriel C.L., Churchill E., Inaki K., et al. (2004) Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem. 279(46):47985-47991.
72. Naghshin J., McGaffin K.R., Witham W.G., et al. (2009). Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice. J. Appl. Physiol. 107(3):787-793.
73. Nandori J., and Nanduri R.P. (2007). Cellular mechanisms associated with intermittent hypoxia. Essays Biochem. 43:91-104.
74. Neckar J., Szarszoi O., Herget J., Ostadal B., and Kolar F. (2003). Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia. Physiol. Res. 52:171-175.
75. Neckar J., Szarszoi O., Koten L., et al. (2002). Effects of mitochondrial Katp modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc. Res. 55:567-575.
76. Ostadal B., and Kolar F. (2007). Cardiac adaptation to chronic high altitude hypoxia: beneficial and adverse effects. Respir. Physiol. Neurobiol. 158:224-236.
77. Ostadal B., Prochazka J., Pelouch V., et al. (1984). Comparison of cardiopulmonary responses of male and female rats to intermittent high altitude hypoxia. Physiologia Bohemoslovaca 33:129-138. (Pubitemid 14107670)
78. Ostadalova I., Ostadal B., Jarkovska D., et al. (2002). Ischemic preconditioning in chronically hypoxic neonatal rat heart. Pediatr. Res. 52:561-567.
79. Philp A., Macdonald A., and Watt P. (2005). Lactate: a signal coordinating cell and systemic function. J. Exp. Biol. 208:4561-4575.
80. Pilar Valle M., Garcia-Godos F., Woolcott O., et al. (2006). Improvement of myocardial perfusion in coronary patients after intermittent hypobaric hypoxia. J. Nucl. Card. 13(1):69-74.
81. Rafiee P., Shi Y., Kong X., et al. (2002). Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation. 106:239-245. (Pubitemid 34761306)
82. Rakuson K., Chcojkova Z., Oliviero P., et al. (2007). ANG II type receptor antagonist irbsartan inhibits coronary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats. Am. J. Physiol. Heart Circ. Physiol. 292(3):H1237-H1244.
83. Razeghi P., Younf M., Abassi S., et al. (2001). Hypoxia in vivo decreases peroxisome proliferator-activated receptor α-regulated gene expression in rat heart. Biochem. Biophys. Res. Commun. 342:5-10.
84. Regensteiner J., and Moore L. (1985). Migration of the elderly from high altitudes in Colorado. JAMA. 253(21):3124-3128. (Pubitemid 15080747)
85. Roach R., Houston C., Honigman B., et al. (1995). How well do older persons tolerate moderate altitude? West J. Med. 162(1):32-36.
86. Rouet-Benzineb P., Eddahibi S., Raffestin B., et al. (1999). Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia. J. Mol. Cell Cardiol. 31:1697-1708.
87. Ruiz L., and Penaloza D. (1977). Altitude and hypertension. Mayo Clin. Proc. 52:442-445.
88. Saurin A.T., Pennington N.J., Raat D.S, et al. (2002). Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc. Res. 55(3):672-680.
89. Schlim D., and Gallie J. (1992). The causes of death among trekkers in Nepal. Int. J. Sports Med. 13:Suppl 1:S74-76.
90. Semenza G. (2004). O2 regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96:1173-1177.
91. Semenza G. (2006). Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 91(5):803-806.
92. Semenza G.L. (2000). Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharm. 59:47-53.
93. Sharma S. (1990). Clinical, biochemical, electrocardiographic and noninvasive hemodynamic assessment of cardiovascular status in natives at high to extreme altitudes of the Himalayan region. Indian Heart J. 42:375-379.
94. Sharma S., Taegtmeyer H., Adrogue J., et al. (2004). Dynamic changes of gene expression in hypoxia induced right ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 286: H1185-H1192.
95. Shinbo A., and Iijima T. (1997). Potentiation by nitric oxide of the ATP-sensitive K current induced by K channel openers in guinea-pig ventricular cells. Br. J. Pharmacol. 120:1568-1574.
96. Singel D.J., and Stamler J.S. (2005). Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemiglobin. Annu. Rev. Physiol. 67:99-145.
97. Sivitz W., Lund D., Yorek B., et al. (1992). Pretranslational regulation of two cardiac glucose transporters in rats exposed to hypobaric hypoxia. Am. J. Physiol. Endocrinol. Metab. 263: E562-E569.
98. Szarszoi O., Asemu G., Ostadal B., et al. (2003). The role of reactive oxygen species and nitric oxide in ischemia/reperfusion injury of chronically hypoxic rat heart. Eur. J. Heart Failure. Suppl 2:53.
99. Tajima M., Katayose D., Bessho M., and Isoyama S. (1994). Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. Cardiovasc. Res. 28: 312-319.
100. Thompson L., Dong Y., and Evans L.(2009). Chronic hypoxia increases inducible NOS-derived nitric oxide in fetal guinea pig hearts. Pediatr. Res. 65(2):188-192.
101. Tissot van Patot M.C., Serkova N.J., et al. (2009). Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding in humans after rapid ascent to 4300m. Free Radical Biol.Med. 46(11):1551-1557.
102. Turek Z., Kubat K., and Ringnalda B. (1980). Experimental myocardial infarction in rats acclimated to simulated high altitude. Basic Res. Cardiol. 75:544-553.
103. Vegh A., Szekeres L., and Parrat J.R. (1992). Preconditioning of the ischemic myocardium: involvement of the L-arginine nitric oxide pathway. Br. J. Pharmacol. 107:648-652.
104. Voors A.W., and Johnson W.D. (1979). Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J. Chronic Dis. 32:157-162. (Pubitemid 10099666)
105. Walsh S.R., Tang T.Y., Kullar P., et al. (2008) Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur. J. Cardiothoracic Surg. 34:985-994.
106. Weitz C.A. (1982). Blood pressure at rest and during exercise among Sherpas and Tibetan migrants in Nepal. Soc. Sci. Med. 16:223-231.
107. World Health Organization. (2009). Cardiovascular diseases fact sheet. Accessed December 2009 〈http://who.int/ mediacentre/factsheets/fs317/en/ print.html〉
108. Wyss C.A., Koepfli P., Fretz G., et al. (2003). Influence of altitude exposure on coronary flow reserve. Circulation. 108:1202-1207. (Pubitemid 37099988)
109. 2+ overload injury. Life Sci. 76:559-572.
110. Yeung H.M., Kravtsov G.M., Ng K.M., Wong T.M., and Fung M.L. (2007). Chronic intermittent hypoxia alters Ca2+ handling in rat cardiomyocytes by augmented Na+/Ca2+ exchange and ryanodine receptor activities in ischemia-reperfusion. Am. J. Physiol. Cell Physiol. 292(6): C2046-2056.
111. Zhu W., Ding H., and Zhou Z. (2003). ATP dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. Life Sci. 73:1275-1287. (Pubitemid 36794592)
112. Zittermann A., Schleitloff S.S., and Koerfer R. (2005). Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94:483-492.